Skip to main content
. 2020 Nov 18;156(2):1–9. doi: 10.1001/jamasurg.2020.5151

Table 3. Primary and Secondary End Points Within 6 Months.

End point Surgery (n = 41) Conservative treatment (n = 44) Effect size (95% CI) P value
Primary outcome
MD in GIQLI score between baseline and 6 mo, mean (SD)a 11.76 (15.89) −0.2 (19.07) MD = 11.96 (3.72-20.19) .005
Secondary outcomes
GIQLI score at 6 mob 114.92 (16.77) 101.97 (21.74) MD = 12.95 (3.98-21.92) .005
SF-36 at 6 mo, median (IQR)c
PCS 51.52 (41.74-55.74) 42.19 (35.67-53.76) r = 0.215d .06
MCS 55.14 (51.38-57.24) 47.68 (41.27-56.82) r = 0.267d .02
Patients with recurrent episodes of diverticulitis within 6 moe
Any 2 (5%) 12 (27%) OR = 8.0 (1.7-38.8) .004
Hinchey I 2 (5%) 12 (27%) NA
Hinchey IIa 0 0 NA
Hinchey IIb 0 0 NA
Hinchey III 0 0 NA
Hinchey IV 0 0 NA
Stoma
Permanent 0 0 NAf >.99
Temporary 2 (5%) 0 NAf .23
Mortality within 6 mo 0 0 NAf >.99

Abbreviations: GIQLI, Gastrointestinal Quality of Life Index; MCS, mental component score; MD, mean difference; NA, not applicable; OR, odds ratio; PCS, physical component score; SF-36, 36-Item Short Form Health Survey.

a

Data missing in 4 patients in the surgery group and 9 patients in the conservative treatment group.

b

Data missing in 3 patients in the surgery group and 8 patients in the conservative treatment group.

c

Data missing in 4 patients in the surgery group and 6 patients in the conservative treatment group.

d

Effect size is given here as r = Z/√N without 95% CI.

e

Data missing in 3 patients in the surgery group and 5 patients in the conservative treatment group.

f

Effect size could not be calculated because of a value of zero in one cell.